Patents by Inventor Eosu Kim

Eosu Kim has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • NOVEL COMPOUND AND PHARMACEUTICAL COMPOSITION COMPRISING SAME AS ACTIVE INGREDIENT
    Publication number: 20250376441
    Abstract: The present invention relates to a novel compound and a pharmaceutical composition comprising the same as an active ingredient. The novel compound, which is obtained by means of carrying out chemical modification in a mother structure showing excellent AMP-activated protein kinase (AMPK) activation efficacy and in silico binding capacity, enables effective prevention or treatment of degenerative neurological disorders by means of effectively inducing AMP-activated protein kinase enzyme activation.
    Type: Application
    Filed: June 30, 2025
    Publication date: December 11, 2025
    Inventors: Eosu Kim, Kee Namkoong, Jihyeon Jeong, Sooah Jang, Young Joo Kwon, Kyu Yeon Jun, Kyung Hwa Jeon, Minsun Park, Hyunjeong Kim, Younghwa Na
  • Composition for prevention, amelioration, or treatment of cancer
    Patent number: 12447137
    Abstract: The alpha-beta unsaturated aryl, heteroaryl and cycloalkylene ketone compounds described herein may be very effectively used not only to prevent, ameliorate or treat cancer, but also to inhibit metastasis of cancer, by inhibiting the growth of cancer cells and very effectively inhibiting the metastasis of cancer cells to other tissues.
    Type: Grant
    Filed: May 27, 2020
    Date of Patent: October 21, 2025
    Assignees: Ewha University—Industry Collaboration Foundation, Cha University Industry-Academic Cooperation Foundation, Industry-Academic Cooperation Foundation, Yonsei University
    Inventors: Youngjoo Kwon, Soo-Yeon Hwang, Hyunji Jo, Seojeong Park, Younghwa Na, Eosu Kim, Jihyeon Jeong, Minsun Park, Hyunjeong Kim
  • Composition for Prevention, Amelioration, or Treatment of Cancer
    Publication number: 20220226263
    Abstract: A composition according to the present disclosure may be very effectively used not only to prevent, ameliorate or treat cancer, but also to inhibit metastasis of cancer, by inhibiting the growth of cancer cells and very effectively inhibiting the metastasis of cancer cells to other tissues.
    Type: Application
    Filed: May 27, 2020
    Publication date: July 21, 2022
    Inventors: Youngjoo Kwon, Soo-Yeon Hwang, Hyunji Jo, Seojong Park, Younghwa Na, Eosu Kim, Jihyeon Jeong, Minsun Park, Hyunjeong Kim
  • NOVEL COMPOUND AND PHARMACEUTICAL COMPOSITION COMPRISING SAME AS ACTIVE INGREDIENT
    Publication number: 20200190024
    Abstract: The present invention relates to a novel compound and a pharmaceutical composition comprising the same as an active ingredient. The novel compound, which is obtained by means of carrying out chemical modification in a mother structure showing excellent AMP-activated protein kinase (AMPK) activation efficacy and in silico binding capacity, enables effective prevention or treatment of degenerative neurological disorders by means of effectively inducing AMP-activated protein kinase enzyme activation.
    Type: Application
    Filed: May 16, 2017
    Publication date: June 18, 2020
    Inventors: Eosu Kim, Kee Namkoong, Jihyeon Jeong, Sooah Jang, Young Joo Kwon, Kyu Yeon Jun, Kyung Hwa Jeon, Minsun Park, Hyunjeong Kim, Younghwa Na